Doctor

Nautilus Biotechnology (NAUT) versus competitive financial analysis

Healing biotechnology (OTCMKTS: CUBT) and agilon health (NYSE: AGL) analysis

Curative biotechnology (OTCMKTS: CUBT – Get Rating) and agilon Health (NYSE: AGL – Get Rating) are both medical companies, but what is the top title? We will compare the two companies based on the strength of analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership, and risk. Institutional and privileged property 96.2% of agilon health shares …

Healing biotechnology (OTCMKTS: CUBT) and agilon health (NYSE: AGL) analysis Read More »

Nautilus Biotechnology (NAUT) versus competitive financial analysis

Zacks: Analysts expect Nautilus Biotechnology, Inc. (NASDAQ: NAUT) to post – $ 0.17 EPS

Analysts expect Nautilus Biotechnology, Inc. (NASDAQ: NAUT – Get Rating) to post earnings per share (EPS) ($ 0.17) for the current quarter, according to Zacks. Zero analysts issued Nautilus Biotechnology earnings estimates, with the lowest EPS estimate coming in at ($ 0.18) and the highest estimate coming in at ($ 0.15). Nautilus Biotechnology reported earnings …

Zacks: Analysts expect Nautilus Biotechnology, Inc. (NASDAQ: NAUT) to post – $ 0.17 EPS Read More »

Nautilus Biotechnology (NAUT) versus competitive financial analysis

Financial Review of Healing Biotechnology (OTCMKTS: CUBT) and Agilon Health (NYSE: AGL).

Healing biotechnology (OTCMKTS: CUBT – Get Rating) and agilon Health (NYSE: AGL – Get Rating) are both medical companies, but what is the best investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends. Evaluation and earnings This table compares the gross …

Financial Review of Healing Biotechnology (OTCMKTS: CUBT) and Agilon Health (NYSE: AGL). Read More »

How next-generation automation technology can improve healthcare revenue management

How next-generation automation technology can improve healthcare revenue management

Today, nearly every role in any industry faces some level of disruption. We are tasked with achieving more with less – less time, fewer resources, less information and often less support. No sector has experienced this more than healthcare. Healthcare professionals, from physicians to administrative coordinators, feel the pressure to simultaneously improve patient outcomes and …

How next-generation automation technology can improve healthcare revenue management Read More »

Nautilus Biotechnology (NAUT) versus competitive financial analysis

Review of Agilon Health (NYSE: AGL) and Curative Biotechnology (OTCMKTS: CUBT)

agilon health (NYSE: AGL – Get Rating) and Curative Biotechnology (OTCMKTS: CUBT – Get Rating) are both medical companies, but which is the best title? We will compare the two assets based on the strength of analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Institutional and privileged property 96.2% of agilon health shares …

Review of Agilon Health (NYSE: AGL) and Curative Biotechnology (OTCMKTS: CUBT) Read More »

Fortress Biotech (NASDAQ: FBIO) was lowered to "Sell" on StockNews.com

Zacks: Analysts Expect Fortress Biotech, Inc. (NASDAQ: FBIO) to Report Earnings Per Share of $ -0.19

Brokers expect Fortress Biotech, Inc. (NASDAQ: FBIO – Get Rating) to post earnings of ($ 0.19) per share for the current quarter, Zacks Investment Research reports. Five analysts have issued earnings estimates for Fortress Biotech, with the lowest EPS estimate coming in at ($ 0.38) and the highest estimate coming in at ($ 0.03). Fortress …

Zacks: Analysts Expect Fortress Biotech, Inc. (NASDAQ: FBIO) to Report Earnings Per Share of $ -0.19 Read More »

PDS Biotechnology (PDSB) will announce quarterly earnings on Wednesday

PDS Biotechnology Co. (NASDAQ: PDSB) Receives Average “Buy” Recommendation from Analysts

Shares of PDS Biotechnology Co. (NASDAQ: PDSB – Get Rating) got an average “Hold” recommendation from the eight brokers covering the company, Marketbeat.com reports. Two analysts rated the stock with a sell recommendation and five gave the company a buy recommendation. The twelve-month average target price among brokers who have updated their coverage on the …

PDS Biotechnology Co. (NASDAQ: PDSB) Receives Average “Buy” Recommendation from Analysts Read More »

Nautilus Biotechnology (NAUT) versus competitive financial analysis

Legend Biotech (NASDAQ: LEGN) vs NRx Pharmaceuticals (NASDAQ: NRXP) Head-to-Head Review

Legend Biotech (NASDAQ: LEGN – Get Rating) and NRx Pharmaceuticals (NASDAQ: NRXP – Get Rating) are both medical companies, but what is the best investment? We will compare the two assets based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and risk Legend Biotech has a beta …

Legend Biotech (NASDAQ: LEGN) vs NRx Pharmaceuticals (NASDAQ: NRXP) Head-to-Head Review Read More »

Nautilus Biotechnology (NAUT) versus competitive financial analysis

Financial analysis: Nautilus Biotechnology (NAUT) versus its rivals

Nautilus Biotechnology (NASDAQ: NAUT – Get Rating) is one of 42 public companies in the “analytical tools” sector, but how does it stand up to its competitors? We will compare Nautilus Biotechnology with related businesses based on its valuation strength, profitability, dividends, institutional ownership, risk, earnings, and analyst recommendations. Analyst ratings This is a summary …

Financial analysis: Nautilus Biotechnology (NAUT) versus its rivals Read More »

Fortress Biotech (NASDAQ: FBIO) was lowered to "Sell" on StockNews.com

StockNews.com updates Fortress Biotech (NASDAQ: FBIO) to “Hold”

Fortress Biotech (NASDAQ: FBIO – Get Rating) was updated by StockNews.com from a “sell” rating to a “hold” rating in a report released Thursday. A number of other research firms also weighed on FBIO. Roth Capital reiterated a “buy” rating on Fortress Biotech shares in a research note on Tuesday, March 29. TheStreet downgraded Fortress …

StockNews.com updates Fortress Biotech (NASDAQ: FBIO) to “Hold” Read More »